Lineage Cell Therapeutics In shares owned by Barclays
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2 | 1 | 2.00 |
| 2025-06-30 | $24k | 26k | 0.91 |
| 2025-03-31 | $89k | 195k | 0.46 |
| 2024-12-31 | $118k | 234k | 0.50 |
| 2024-09-30 | $192k | 211k | 0.91 |
| 2024-06-30 | $51k | 51k | 0.99 |
| 2024-03-31 | $139k | 94k | 1.48 |
| 2023-12-31 | $200k | 183k | 1.09 |
| 2023-09-30 | $28k | 24k | 1.17 |
| 2023-06-30 | $36k | 26k | 1.39 |
| 2023-03-31 | $21k | 14k | 1.52 |
| 2022-12-31 | $33k | 28k | 1.17 |
| 2022-09-30 | $9.0k | 7.6k | 1.18 |
| 2022-03-31 | $31k | 20k | 1.52 |